about us

Song Biotechnologies, LLC is a Contract Research Organization (CRO) that was founded in 2015 with a vision of providing the research community direct access to the highest level of in vivo microcirculatory analysis through intravital and epi-illumination techniques. Our mission is to provide a full spectrum of solutions consisting of both standard and novel technologies that improve the performance and operational effectiveness of our clients and scientific collaborators.

Utilizing Köhler illumination microscopy with cutting edge phosphorescence and fluorescence techniques, our in vivo microcirculatory core capabilities include measuring interstitial and intravascular oxygenation, blood flow, endothelial dysfunction, and more. In addition, our setup can be reconfigured and modified to accommodate different animal models and parameters of interest.

Although our research focuses on in vivo cardiovascular and microcirculatory parameters, we have ex vivo and in vitro capabilities as well. The scientific team at Song Biotechnologies, LLC is experienced in both academic and government-funded settings, which has informed our commitment to completing projects in a prompt and efficient manner. We acknowledge that time is valuable to our clients and collaborators; therefore, we consistently strive to exceed our clients’ expectations with timely data collection and analysis, and on-site, personalized presentation of our results. Strengthen your business and broaden your understanding of your product’s capabilities by partnering with Song Biotechnologies, LLC in your Research and Development and/or Testing and Evaluation initiatives.